Related references
Note: Only part of the references are listed.Serum levels of osteopontin predict major adverse cardiovascular events in patients with severe carotid artery stenosis
Federico Carbone et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)
The biology and role of CD44 in cancer progression: therapeutic implications
Chen Chen et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Cancer immunotherapy using checkpoint blockade
Antoni Ribas et al.
SCIENCE (2018)
OPG, OPN, EGF and VEGF Levels at Individual Breslow Score Stages in Malignant Melanoma
Inka Treskova et al.
ANTICANCER RESEARCH (2018)
Osteopontin alters DNA methylation through up-regulating DNMT1 and sensitizes CD133+/CD44+cancer stem cells to 5 azacytidine in hepatocellular carcinoma
Xiaomei Gao et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
The osteopontin-CD44 axis in hepatic cancer stem cells regulates IFN signaling and HCV replication
Takayoshi Shirasaki et al.
SCIENTIFIC REPORTS (2018)
An osteopontin/CD44 immune checkpoint controls CD8(+) T cell activation and tumor immune evasion
John D. Klement et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
IMMUNOTHERAPY PD-1 says goodbye, TIM-3 says hello
Diana Romero
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Osteopontin Bridging Innate and Adaptive Immunity in Autoimmune Diseases
Nausicaa Clemente et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2016)
Anti-PD-1/PD-L1 therapy of human cancer: past, present, and future
Lieping Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Aberrant methylation and silencing of IRF8 expression in non-small cell lung cancer
Makoto Suzuki et al.
ONCOLOGY LETTERS (2014)
TGF-beta 2: A Novel Target of CD44-Promoted Breast Cancer Invasion
Allal Ouhtit et al.
JOURNAL OF CANCER (2013)
Osteopontin; as a Target Molecule for the Treatment of Inflammatory Diseases
Junko Morimoto et al.
CURRENT DRUG TARGETS (2010)
Thrombin-Activatable Carboxypeptidase B Cleavage of Osteopontin Regulates Neutrophil Survival and Synoviocyte Binding in Rheumatoid Arthritis
Shadi A. Sharif et al.
ARTHRITIS AND RHEUMATISM (2009)
CD44 Variant Isoforms in Head and Neck Squamous Cell Carcinoma Progression
Steven J. Wang et al.
LARYNGOSCOPE (2009)
IFN regulatory factor 8 mediates apoptosis in nonhemopoietic tumor cells via regulation of fas expression
Dafeng Yang et al.
JOURNAL OF IMMUNOLOGY (2007)
Osteopontin: role in cell signaling and cancer progression
H Rangaswami et al.
TRENDS IN CELL BIOLOGY (2006)
Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival
DT Denhardt et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Share Paper
